Suave, Singla M, Gupta S, Singh H. Protocol for a randomized controlled study comparing the efficacy and safety of daily versus alternate day teneligliptin 20 mg in type 2 diabetes mellitus patients. Int J Clin Trials [Internet]. 2025 Apr. 28 [cited 2025 Jun. 16];12(2):153-62. Available from: https://www.ijclinicaltrials.com/index.php/ijct/article/view/865